RA
Rapport Therapeutics, Inc. Common Stock (RAPP)
NASDAQ·Healthcare·Biotechnology
$41.26
-1.67%
Mkt Cap $1.51B
Analyst Ratings
Buy
6
Hold
0
Sell
0
Price Target (11 analysts)
$56.40
Range $43.00 – $66.00
Implied Upside
+36.7%
Consensus $56.40 vs current $41.26